STAT

MAY 9, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by our window is picking up, and the official mascots are busy foraging for snacks on the official grounds. Our choice today is orange cream.

221

221

STAT

MAY 3, 2023

That’s very good news for a company that’s racing to reach more patients in hopes of building a sustainable business. Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment for attention deficit hyperactivity disorder is effective for adults.

242

242

STAT

JUNE 30, 2023

But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. Molina said in a news release that Bright’s current book of business generates $1.8 Regulators must approve the deal.

230

230

STAT

SEPTEMBER 7, 2023

Researchers and business groups have been calling for such a deal for months, warning that without membership, the U.K. Research institutions widely celebrated the news that a deal had been struck. risked being left behind even as it aspires to cement itself as a scientific and technology powerhouse.

259

259

STAT

MAY 17, 2023

I was greatly relieved by this news. I was a little more than a year into a wildly busy job at a news media startup. Instead of urging women to get mammograms beginning at 40, it would now recommend yearly mammograms beginning at age 45, and then every two years from age 55 on.

246

246

STAT

SEPTEMBER 7, 2023

Josh Schimmer and Eric Schmidt, two longtime analysts teaming up at Cantor Fitzgerald, join us for a back-to-school conversation as biotech enters the busy back third of 2023. We also discuss the latest news in the life sciences, including some scientific evolution at Biogen, new leadership at Illumina, and the future of CRISPR medicine.

227

227

STAT

JANUARY 25, 2024

Gilead needs Arcellx more than ever The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business.

214

214

STAT

APRIL 20, 2023

Our colleague Helen Branswell joins us to explain the latest news on Covid-19 boosters and the implications of a Marburg outbreak in Equatorial Guinea. We also break down the rest of the week’s biggest news in biopharma, including some billion-dollar deals and the retirement of perhaps the most storied executive in the business.

Vaccines 211

Vaccines 211

Express Pharma

MAY 12, 2024

Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5

73

73

STAT

SEPTEMBER 22, 2023

Hired someone new and exciting? Share the news with us, and we’ll share it with others.   Previously, he worked at Nkarta, where he was chief financial and business officer. Promoted a rising star? Finally solved that hard-to-fill spot?   That’s right. Send Don’t be shy.

222

222

STAT

AUGUST 23, 2023

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund. Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT.

Documentation 243

Documentation 243

STAT

MAY 10, 2024

Here are a few news tidbits before you get on your way. Sales of Novavax’s Covid shot have sputtered along, and last year, the Maryland-based company warned that it may not be able to stay in business. Spring has fully sprung here in the U.K.,

Vaccines 192

Vaccines 192

STAT

APRIL 9, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official mascots are busy foraging for snacks on the official grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

Vaccines 166

Vaccines 166

STAT

OCTOBER 27, 2022

How is the music business like biotech investing? We also discuss the latest news in the life sciences, including the potential effects of federal drug-price negotiation and the virtues of befriending Pharrell Williams. Can Covid denialism get you elected? And what’s at stake for science in the midterms? Read the rest…

Drug Pricing 217

Drug Pricing Vaccines 217

STAT

MAY 4, 2023

We also discuss the latest news in the life sciences, including a busy week of earnings, a long-awaited FDA approval, and the highlights from STAT’s Breakthrough Summit in San Francisco. Read the rest…

190

190

STAT

NOVEMBER 8, 2022

Following a year of executive shakeups and business rejiggering, Talkspace’s third-quarter earnings came with some good news: The company finally appointed a new CEO and key numbers continue to point in the right direction.

190

190

STAT

MARCH 1, 2024

Hired someone new and exciting? Share the news with us, and we’ll share it with others. That’s Previously, she worked at Kira Pharma, where she was head of business development and strategy. Promoted a rising star? Finally solved that hard-to-fill spot?  That’s right. Send Don’t be shy.

199

199

STAT

APRIL 27, 2023

Andrew Joseph, STAT’s Europe correspondent, joins us to explain the EU’s sweeping proposal to overhaul how new drugs are regulated on the continent — and why the pharmaceutical industry is fighting it. Read the rest…

164

164

STAT

DECEMBER 12, 2022

But that business is now firmly in the past, and the company has switched to an even more regulated industry: health insurance. A BuzzFeed News story quoted scientists who thought “the FDA was holding Curative to an unreasonably high standard.” Last year, Curative had a cloud hanging over its head.

Health Insurance Companies 234

Health Insurance Companies 234

Pharmaceutical Commerce

FEBRUARY 4, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

69

69

Pharmaceutical Commerce

APRIL 2, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

STAT

JANUARY 4, 2024

Rise and shine, everyone, another busy day is on the way. We will draw on a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” Sadly, gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless.

Biosimilars 276

Biosimilars Diabetes 276

STAT

JANUARY 10, 2024

The news of another potential drug to treat menopause is more evidence of a growing trend, according to Kelly Casperson, an urologist and menopause specialist. “Menopause is turning into big business,” she says. in December. Continue to STAT+ to read the full story…

Labelling 242

Labelling 242

STAT

FEBRUARY 22, 2023

And what better way to make the time fly than to keep busy. Our in-basket has been outfitted to accept postcards and telegrams. … Eli Lilly says that all doses of its new Mounjaro diabetes drug are now available after social-media enthusiasm about weight-loss benefits sparked a two-month-long shortage , Bloomberg News tells us.

Diabetes 206

Diabetes Labelling 206

Pharmaceutical Commerce

JANUARY 23, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

STAT

JULY 6, 2023

As for us, we are busy with the usual sorts of things. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the drug will aggravate racial disparities in elder care , KFF Health News explains. Drugmakers are asking the U.S.

Drug Pricing 154

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 154

STAT

AUGUST 31, 2023

in coming days, a move that is hoped to increase access to the life-saving medicine amid a worsening opioid epidemic , NBC News tells us. … The opioid overdose antidote Narcan will be available over the counter in the U.S.

217

217

STAT

FEBRUARY 14, 2023

Rise and shine, everyone, another busy day is on the way. … The biotech industry is in shake-out mode after the ranks of public drug developers swelled in recent years amid an IPO boom , Bloomberg News tells us. A Our choice today is Vermont maple walnut, and we invite you to join us.

Drug Development 216

Drug Development 216

STAT

OCTOBER 27, 2022

Rise and shine, another busy day is on the way. This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. billion in profit by transferring money to units in other countries , Bloomberg News reports. Autumn, after all, is in full swing.

Packaging 198

Packaging Vaccines 198

The Guardian - Pharmaceutical Industry

APRIL 25, 2023

The opposition leader, Peter Dutton, has already lent support for the campaign, encouraging patients to ask pharmacists how “the proposed changes will impact you as a customer and them as a local small business”. Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup Continue reading.

47

47

Drug Channels

JULY 27, 2021

Costco beats Medicare Part D Plus, math madness with Duke’s Fuqua business school. In this issue: The top 10 stingiest hospitals Medicare Part B's savings from biosimilars What happened to hepatitis C drug costs and rebates? You can also find me on LinkedIn , where I have more than 19,000 followers.

Biosimilars 52

Biosimilars Hospitals Drug Pricing 52

Express Pharma

APRIL 13, 2023

Hikma Pharmaceuticals announced that Riad Mishlawi, President of the group’s injectables business, will become its CEO, effective Sept. The firm said Mishlawi will join the board and relocate from Portugal to the company’s US headquarters in Berkeley Heights, New Jersey.

86

86

European Pharmaceutical Review

APRIL 2, 2024

With his proven leadership capabilities, Wolfgang is ideally placed to act as an ambassador for our business and lead our colleague community as Lonza enters the next chapter of its growth journey,” shared Albert Baehny, Chairman of the Board of Directors and CEO ad interim, Lonza. billion.

81

81

STAT

OCTOBER 24, 2023

Rise and shine, everyone, another busy day is on the way. Please feel free to join us. … European authorities asked four companies, including Novo Nordisk and Eli Lilly, to provide more information about possible anesthesia complications from weight-loss and diabetes drugs , Bloomberg News says.

Drug Pricing 211

Drug Pricing Diabetes 211

STAT

FEBRUARY 1, 2024

On Wall Street, that spells bad news for the riskier segments of the market, which includes biotech, and thus the XBI dipped about 2%. Biotech’s November resurgence had less to do with the fundamentals of making new drugs than it did with the Fed’s decision to stop raising rates.

Drug Pricing 268

Drug Pricing Vaccines Communication Drug Development 268

Drug Patent Watch

OCTOBER 20, 2021

DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of….

72

72

STAT

AUGUST 3, 2023

As for us, we are dutifully concocting a few needed cups of stimulation as we dig in for another busy day. A Louisiana woman filed a lawsuit claiming that Novo Nordisk and Eli Lilly failed to adequately warn patients about the possible risk of severe stomach problems associated with their drugs, Ozempic and Mounjaro, NBC News reports.

Labelling 197

Labelling Diabetes 197